1 / 4

Global Xeljanz Tofacitnib Drug Market, Size, Share, Analysis Report & Forecast

The global xeljanz tofacitnib market is anticipated to grow at a significant CAGR during the forecast period (2021-2027).

alfahadkhan2510
Télécharger la présentation

Global Xeljanz Tofacitnib Drug Market, Size, Share, Analysis Report & Forecast

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Xeljanz Tofacitnib Drug Market, Size, Share, Analysis Report & Forecast to 2026 Global Xeljanz Tofacitnib Drug Market Size, Growth Analysis Report, Forecast to 2027 Global Xeljanz Tofacitnib Drug Market Size, Growth Analysis Report, Forecast to 2027 Global Xeljanz Tofacitnib Drug Market: Report Based on Development, Scope, Share, Trends, Forecast to 2027 Global Xeljanz Tofacitnib Drug Market Trends | Segmentation, Outlook, Industry Report to 2021-2027 The global xeljanz tofacitnib market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factor for the growth of the market is the increase in the number of arthritis patients which include patients suffering from rheumatoid arthritis, psoriatic arthritis, and ulcerative arthritis. According to the Global RA Network, around 350 million people across the globe are suffering from arthritis. Arthritis caused the US healthcare system to spend around $303 billion each year, according to the data submitted by the Centers for Disease Control and Prevention (CDC). This, in turn, is driving the demand for xeljanz tofacitnib drugs for the treatment of arthritis patients. Free Sample Copy @ https://www.omrglobal.com/request-sample/xeljanz-tofacitnib-drug- market

  2. The drug is marketed under the name of Xeljanz by Pfizer; it is a Janus kinases drug. The drug targets the reduction of inflammation caused by rheumatoid arthritis, by inhibiting the janus kinases which is involved in the inflammatory response pathway. In August 2021, the European Commission (EC) had approved the drug for the treatment of arthritis in Europe, which will further increase the demand for these drugs. A Full Report of Global Xeljanz Tofacitnib Drug Market is Available at: https://www.omrglobal.com/industry-reports/xeljanz-tofacitnib-drug-market In addition to this, the EC has also approved the prolonged-release 11 mg version of the drug for the treatment of patients suffering from JPsA (juvenile psoriatic arthritis). In August 2021, Zydus Cadila, which is a part of Cadila Healthcare, received the final approval for the 180- days exclusivity for Xeljianz generic in the US. Global Xeljanz Tofacitnib Drug Market – Segmentation By Type •Tablets •Extended-Release Tablets By Application •Rheumatoid Arthritis •Psoriatic Arthritis •Other Global Xeljanz Tofacitnib Drug Market – Segmentation by Region North America •United States •Canada Europe •Germany •United Kingdom •France •Spain •Italy •Rest of Europe Asia-Pacific

  3. •China •Japan •India •Rest of Asia-Pacific Rest of the World Company Profiles •Novartis Inc. •Eli Lilly •Pfizer Inc. •AbbVie •Zydus Cadila •Teva Pharmaceuticals •Cipla •Natco Pharma •Intas Biopharmaceuticals For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/xeljanz-tofacitnib-drug-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

  4. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

More Related